161 related articles for article (PubMed ID: 15032309)
1. The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice.
Widera A; Bai Y; Shen WC
Pharm Res; 2004 Feb; 21(2):278-84. PubMed ID: 15032309
[TBL] [Abstract][Full Text] [Related]
2. Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers.
Widera A; Kim KJ; Crandall ED; Shen WC
Pharm Res; 2003 Aug; 20(8):1231-8. PubMed ID: 12948021
[TBL] [Abstract][Full Text] [Related]
3. Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent.
Bai Y; Ann DK; Shen WC
Proc Natl Acad Sci U S A; 2005 May; 102(20):7292-6. PubMed ID: 15870205
[TBL] [Abstract][Full Text] [Related]
4. Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization.
Bai Y; Shen WC
Pharm Res; 2006 Sep; 23(9):2116-21. PubMed ID: 16952003
[TBL] [Abstract][Full Text] [Related]
5. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
Xia CQ; Shen WC
Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
[TBL] [Abstract][Full Text] [Related]
6. Albugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys.
Halpern W; Riccobene TA; Agostini H; Baker K; Stolow D; Gu ML; Hirsch J; Mahoney A; Carrell J; Boyd E; Grzegorzewski KJ
Pharm Res; 2002 Nov; 19(11):1720-9. PubMed ID: 12458679
[TBL] [Abstract][Full Text] [Related]
7. Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells.
Shah D; Shen WC
J Pharm Sci; 1996 Dec; 85(12):1306-11. PubMed ID: 8961144
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption.
Lim CJ; Norouziyan F; Shen WC
J Control Release; 2007 Oct; 122(3):393-8. PubMed ID: 17586083
[TBL] [Abstract][Full Text] [Related]
9. Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs.
Lim CJ; Shen WC
J Control Release; 2005 Sep; 106(3):273-86. PubMed ID: 15964654
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats.
Xia CQ; Wang J; Shen WC
J Pharmacol Exp Ther; 2000 Nov; 295(2):594-600. PubMed ID: 11046093
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
Sugiura M; Yamamoto K; Sawada Y; Iga T
Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of transferrin receptor gene expression by granulocyte colony-stimulating factor in human myeloid leukemia cells.
Morishita Y; Kataoka T; Towatari M; Ito T; Inoue H; Ogura M; Morishima Y; Saito H
Cancer Res; 1990 Dec; 50(24):7955-61. PubMed ID: 1701357
[TBL] [Abstract][Full Text] [Related]
13. The establishment of polarity and enhanced transcytosis of transferrin receptors in enterocyte-like Caco-2 cells.
Shah D; Shen WC
J Drug Target; 1994; 2(2):93-9. PubMed ID: 8069597
[TBL] [Abstract][Full Text] [Related]
14. Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.
Ahn LY; Shin KH; Lim KS; Kim TE; Jeon H; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Drug Investig; 2013 Nov; 33(11):817-24. PubMed ID: 24078278
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).
Lord BI; Woolford LB; Molineux G
Clin Cancer Res; 2001 Jul; 7(7):2085-90. PubMed ID: 11448927
[TBL] [Abstract][Full Text] [Related]
16. Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with metastatic breast cancer.
Kennedy MJ; Davis J; Passos-Coelho J; Noga SJ; Huelskamp AM; Ohly K; Davidson NE
Cancer Res; 1993 Nov; 53(22):5424-8. PubMed ID: 7693341
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XM02 equivalent to marketed filgrastim Neupogen: single-blind, randomized, crossover trial.
Lubenau H; Bias P; Maly AK; Siegler KE; Mehltretter K
BioDrugs; 2009; 23(1):43-51. PubMed ID: 19344191
[TBL] [Abstract][Full Text] [Related]
18. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of neutrophils in mice exposed to radiation and/or granulocyte colony-stimulating factor treatment.
Romero-Weaver AL; Wan XS; Diffenderfer ES; Lin L; Kennedy AR
Radiat Res; 2013 Aug; 180(2):177-88. PubMed ID: 23829559
[TBL] [Abstract][Full Text] [Related]
20. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
